Law360, New York (November 06, 2009) -- The U.S. Department of Justice is investigating the way Abbott Laboratories has sold and marketed the anti-seizure drug Depakote, the company said Friday.
In a financial report with the U.S. Securities and Exchange Commission, Abbott said the U.S. Attorney's Office for the Western District of Virginia was trying to determine whether the company's...
